reports
- Carole Braudeau
Credit Morning 11/20/2024
Grifols: the board considers that Brookfield’s indicative price undervalues the company Teva: S&P upgrades the rating to BB/positive from BB/positiveElior: Results recovered in 2023-24, exceeding expectations. Debt reduction is making headway as planned.Tereos: Sharp decline in EBITDA in Q2 24/25. The financial position is stable thanks to the generation of FCF.>...
- Damien Choplain
- Martial Descoutures
- Carole Braudeau
Morning Crédit 20/11/2024
Grifols : le conseil d’administration estime que le prix indicatif proposé par Brookfield sous-évalue la sociétéTeva: S&P upgrades the rating to BB/positive from BB/positiveElior: les résultats se sont redressés 2023/24, dépassant les attentes. Le désendettement progresse comme prévu.Tereos : fort repli de l'EBITDA au T2 24/25. La situation financière est stable grâce à la génération de FCF.>...
- Damien Choplain
- Martial Descoutures
RHM RHEINMETALL AG
BLND BRITISH LAND COMPANY PLC
GRF GRIFOLS S.A. CLASS A
ELE ENDESA S.A.
ISP INTESA SANPAOLO S.P.A.
TLX TALANX AG
UCG UNICREDIT S.P.A.
CABK CAIXABANK SA
GRF.P GRIFOLS S.A. PREF CLASS B
ARGX ARGEN-X SE
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
SGSN SGS SA
- Research Department
IBERIAN DAILY 20 NOVEMBER (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: CAIXABANK, ENDESA, GRIFOLS, POSSIBLE TAX CHANGES, TALGO. Russia shakes markets The threat of using nuclear weapons by Russia after Ukraine used its long-range missiles on Russian territory led to corrections in European stock markets that eased throughout the session after the Foreign Minister S. Lavrov stressed that Russia does not wish nor expect a nuclear war. Thus, in the STOXX 600, Real Estate and Pharma were the only sectors ending with gains vs. Banks and Automobiles that ...
- Benoit Valleaux
- Steven Gould
CaixaBank : The medium-term strategic update underpins our positive ca...
>Outperform rating confirmed – Target price adjusted to € 7.0 (vs € 7.2) - The medium-term strategic update (CMD held yesterday) from CaixaBank confirms our positive approach to the stock and its place among our sector Top Picks. Unsurprisingly, the group intends to capitalise/strengthen solid achievements (top-line diversification, operating efficiency, healthy asset quality, etc.) while emphasising the notable potential for activity growth (which is a change from th...
- Benoit Valleaux
- Steven Gould
CaixaBank : L’update stratégique MT conforte notre call positif
>Opinion Surperformance confirmée – OC ramené à 7.0 € (vs 7.2 €) - L’update stratégique MT (CMD tenu hier) réalisé par CaixaBank vient confirmer notre approche positive sur le titre et sa place parmi nos top picks au sein du secteur. Sans surprise le groupe compte capitaliser/renforcer de solides acquis (diversification topline, efficience opérationnelle, qualité d’actifs saine…) tout en insistant sur le potentiel notable de croissance de l’activité (ce qui change vs ...
- Javier Esteban
CAIXABANK: OBJETIVOS AMBICIOSOS PARA TIPOS BAJOS; CAMBIO DE RECOMENDAC...
Plan estratégico ambicioso para un escenario de tipos conservador. Cambio de recomendación a INFRAPONDERAR. CABK aspira a ROTE medio 25-27 >15% (14,1% BS(e) y 14,5% consenso) y >16% en 2027 (implicaría en media un BDI +15% por encima de lo esperado). Prevé compensar EURIBOR bajo (2,19% en 2025, 1,8% en 2026 y 2% en 2027( vs 2,5% nosotros)) con más volumen de crédito y coberturas ALCO. Mantiene política de dividendo en cash (50%- 60% payout/ ~7-8% yield). Distribuirá el exceso de capital >12,5% C...
Bayer AG: 1 director
A director at Bayer AG bought 11,278 shares at 20.745EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
- Research Department
IBERIAN DAILY 19 NOVEMBER (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: CAIXABANK, POSSIBLE TAX CHANGES, SOLARIA. Awaiting drivers European stock markets managed to recover ground at the end of the session, ending mixed, with the Ibex and FTSE MIB being the best relative performers. Thus, in the STOXX 600, Basic Resources and Telecoms were the best relative performers vs. the bigger drops of Real Estate and Retail. From the ECB, De Guindos insisted that concerns about inflation have now shifted to growth. On the macro side, in the US November’s NAHB r...
- Research Department
INFORME DIARIO 19 NOVIEMBRE (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAIXABANK, IMPUESTOS ESPAÑA, SOLARIA. A la espera de catalizadores Las bolsas europeas lograron recuperarse hacia el final de la sesión y cerraron con signo mixtos donde destacó el buen comportamiento relativo del Ibex y el del FTSE MIB en negativo. Así, dentro del STOXX 600, Recursos Básicos y Telecos mostraron el mejor comportamiento relativo, frente a las mayores caídas de Inmobiliario y Retail. Desde el BCE, De Guindos insistió en que la preocup...
- Research Department
IBERIAN DAILY 15 NOVEMBER + 3Q’24 RESULTS. PREVIEWS (ANÁLISIS BANCO SA...
NEWS SUMMARY: ACCIONA, ACCIONA ENERGÍA, CAF, CAIXABANK, COLONIAL, MERLIN. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 3Q’24 results to be released over the coming days in Spain. ECB’s target nearly met The Euro STOXX 50 had its best day since late September, while the ECB’s meeting minutes suggested the 2% inflation target will be met earlier than expected, thus cementing t...
- Research Department
INFORME DIARIO 15 NOVIEMBRE + RDOS. ESPAÑA 3T’24. PREVIEWS (ANÁLISIS B...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACCIONA, ACCIONA ENERGÍA, CAF, CAIXABANK, COLONIAL, MERLIN. EUROPA: ASML, SANOFI. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. El BCE con el objetivo casi cumplido El Euro STOXX 50 tuvo su mejor día desde finales de septiembre mientras las ...
- Benoit Valleaux
- Steven Gould
CaixaBank : Medium-term strategic update: underpinning win/win profile...
We maintain our Outperform rating on CaixaBank, one of our Top Picks in the sector, with a higher target of € 7.2 vs € 6.7 and ahead of the CMD on 19 November. We are lifting our net income estimates by 7% for 2025-2026, to 7% above the consensus. The strategic update is set to highlight the wisdom of the business model diversification (long-term savings) to address the current transition phase on rates. Despite a solid market performance, the profile does not look to be fully r...
- Benoit Valleaux
- Steven Gould
CaixaBank : Update stratégique MT : conforter le profil ‘win/win’ face...
Nous réitérons notre opinion Surperformance sur CaixaBank, l’un de nos top picks du secteur, avec un OC porté à 7.2 € vs 6.7 € et en amont du CMD du 19/11. Nous relevons nos anticipations de RN de 7% sur 2025/2026 qui ressortent 7% supérieures au consensus. L’update stratégique devrait mettre en avant la pertinence de la diversification du business model (épargne LT) face à la transition actuelle sur les taux. Malgré un solide parcours boursier, cela n’est pas pleinement reflété ...
- Christophe-Raphaël Ganet
- Fehmi Ben Naamane
- Marc Lavaud
TEMN TEMENOS AG
ZIL2 ELRINGKLINGER AG
UTDI UNITED INTERNET AG
ELG ELMOS SEMICONDUCTOR SE
BOSS HUGO BOSS AG
TPE PVA TEPLA AG
ERA ERAMET SA
SIX2 SIXT SE
COK CANCOM SE
KENDR KENDRION NV
TWEKA TKH GROUP N.V. CERT
NHH NH HOTEL GROUP SA
ALM ALMIRALL SA
JUN3 JUNGHEINRICH AG PREF
JEN JENOPTIK AG
SFQ SAF-HOLLAND SE
RWI RENEWI PLC
FORSE FORSEE POWER SA
- Christophe-Raphaël Ganet
- Marc Lavaud
- Martin Marandon-Carlhian
- Stephane Houri
- Christophe-Raphaël Ganet
- Fehmi Ben Naamane
- Marc Lavaud
TEMN TEMENOS AG
ZIL2 ELRINGKLINGER AG
UTDI UNITED INTERNET AG
ELG ELMOS SEMICONDUCTOR SE
BOSS HUGO BOSS AG
TPE PVA TEPLA AG
ERA ERAMET SA
SIX2 SIXT SE
COK CANCOM SE
KENDR KENDRION NV
TWEKA TKH GROUP N.V. CERT
NHH NH HOTEL GROUP SA
ALM ALMIRALL SA
JUN3 JUNGHEINRICH AG PREF
JEN JENOPTIK AG
SFQ SAF-HOLLAND SE
RWI RENEWI PLC
FORSE FORSEE POWER SA
- Christophe-Raphaël Ganet
- Marc Lavaud
- Martin Marandon-Carlhian
- Stephane Houri
- Michael B. Schäfer
- Stephan Wulf
Bayer : Weaker-than-expected Q3 results and cut in group’s adj. EBITDA...
>Group’s adj. EBITDA significantly below expectations - At a group level, Bayer’s Q3 sales of € 9.97bn (-3.6%), were below our (€ 10.2bn) and consensus estimates (€ 10.1bn), the group’s EBITDA of € 1,251m (-26%) came in 9% weaker than we expected (€ 1,376m) and was 5% below the consensus (€ 1,313m). The significant group’s EBITDA decline vs Q3 2023 was driven by the Pharma division, which came in at € 1,102m (23.4% below Q3 2023). Adjusted EPS of € 0.24 was 37% below ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.